相关实验视频

Updated: May 23, 2025

Knee Arthrocentesis in Adults

Knee Arthrocentesis in Adults

Published on: February 25, 2022

放射性关节切除术:对于炎症性关节疼痛的一个诱人的治疗选择

Ashutosh Dash¹, Tapas Das^2,3

¹Raja Ramanna Fellow, Bhabha Atomic Research Centre, Mumbai 400085, India.

Pain research & management

|May 21, 2025

概括

放射性关节切除术 (RSV) 使用向放射性微粒来治疗慢性关节炎症. 这种核医学疗法有效地向炎症组织,为手术提供一种微创的替代方案.

科学领域:

核医学是一种核医学.
放射性药物疗法是一种放射性药物疗法.
类风湿病学类风湿病学

背景情况:

慢性炎症关节疾病往往会抵抗传统治疗.
放射性核切除术 (RSV) 是治疗这种疾病的先进核医学疗法.
放射性肺炎病毒 (RSV) 涉及放射性微粒的关节内注射,向炎症的突膜.

研究的目的:

审查放射性新细胞切除术 (RSV) 的演变和进展.
详细说明RSV的机制,选择标准和放射性核酸和微粒的开发.
评估当前RSV方法在治疗关节疾病中的有效性.

主要方法:

关于放射性核核切除术 (RSV) 演变和放射性核素/微粒子发展的文献综述.
对影响放射性核素和微粒子选择的核和化学性质的分析.
在RSV治疗中常用的放射性核素和微粒的评估.

主要成果:

RSV已经从放射性体演变为用于各种关节的专门剂.
选择最佳的放射性核素取决于核/化学特性,以获得有效性.
新型微粒子提高了RSV的特异性和治疗结果.

结论:

放射性突触切除术 (RSV) 是对慢性炎症关节疾病的一种显著的,最少侵入性的核医学治疗方法.
目前正在进行的研究重点是放射性核素和微粒子开发,以提高RSV的疗效和特异性.
RSV提供了一种有价值的治疗选择,随着有针对性的放射性药物创新而发展.

关键词:

辐射协同切除术是指辐射协同切除术.放射性标记的合物合物带有放射标记的微粒子类风湿性关节炎类风湿性关节炎综合生殖方式 synovectomy.突关节突关节突关节

更多相关视频

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...